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Abstract
Background: The study investigated predictors of  poor glycemic control in type 2 diabetes (T2DM).
Methods:  Data on demographics, anthropometric and clinical parameters were collected in a cross-section survey from 140 
adults with T2DM, using standard tools/instruments.  Glycated hemoglobin (A1C) was assessed as a measure of  glycemic con-
trol.  
Results: Majority (83.3%) had poor glycemic control status of  which about 95% constitute the elderly.  The elderly (OR= 5.90, 
95% Cl: 1.66-20.96) were more likely associated with poor glycemic control than the non-elderly (p = 0.006). Adjustment for 
significant predictor variables: Age, waist-hip ratio (WHR), Fasting plasma glucose (FPG) and Systolic blood pressure (SBP), 
although attenuated the odds (OR= 5.00, 95% CI: 1.19-20.96) of  poor glycemic control, it still remained significantly (p = 0.028) 
higher in the elderly. Patients outside tight FPG control significantly (p = 0.001) showed poor glycemic cotrol than those within 
tight FPG (OR= 17.39, 95%Cl: 5.83-51.90), even with attenuated OR (OR= 10.85, 95%Cl: 3.10-37.96) and (OR=12.08, 95%Cl: 
3.64-40.09) when non- significant and significant predictor variables were accounted for, respectively.
Conclusion: Age, WHR, FPG, and SBP were significantly associated with differences in glycemic control. The elderly and FPG 
outside tight control showed significantly increased odds of  poor glycemic control status.
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Introduction
The growing incidence of  type 2 diabetes mellitus 
(T2DM) would likely heighten the prevalence of  DM 
globally, with about 11% adults (approximately 114 mil-
lion) currently suffering with T2DM.  This is projected 
to increase to about 150 million by 20401, with 80% of  
the cases occurring among population in resource-poor 
settings2. In Africa, the estimated prevalence of  diabetes 
is 1% in rural areas, and about 5% to 7% in urban sub-Sa-
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haran Africa3, with Nigeria having the highest burden of  
the disease4.  Data from National Survey on Non-Com-
municable Disease indicates that the prevalence of  DM 
in Nigeria was 2.2% in19975. In 2015, this has increased 
to 5.0%4. Although, the current prevalence of  DM in Ni-
geria is not well documented, however, this may possibly 
vary between 8%-10%6. Epidemiological evidence indi-
cates an increasing burden of  T2DM among adult Nige-
rian (20-79 years) with about 874 000  cases representing 
2.0%  estimated  prevalence rates in 1990 to 4.7 million 
cases (5.7%)  in 20157. Females have higher prevalence 
than males8,9. However, prevalence increases with ageing 
in both sexes8.
Regardless of  sex, maintaining tight glycemic control 
among patients is fundamental in preventing complica-
tions associated with the disease. Several factors, both 
clinical and non-clinical factors, have been noted to im-
pact the level of  glycemic control in individuals. For in-
stance, there are few non-modifiable (e.g. ethnicity, age, 
family history/genetic factor, sex) and modifiable (e.g. 
excess alcohol intake, smoking, physical inactivity, un-
healthy diet, educational status, metabolic abnormalities 
and obesity/overweight) factors reported to influence 
the outcome of  T2DM management4,8. Interestingly, pri-
or studies1,10,11, have reported ethnic difference particu-
larly in T2DM. Perhaps, given the  ethnic disparities in 
glycemic control12 arising from the  differences in the 
distribution of  critical risk factors that impact glycemic 
control such as age1,13, sex, social economic status, body 
mass index (BMI)1, lifestyles, processes of  care/adher-
ence to treatment14,15,16,18,  blood pressure and duration 
of  the disease16,17,18  etc. However, in Nigeria- especially 
South-Eastern part, there still remains dearth of  data re-
garding glycemic control status, a pivotal step for achiev-
ing marked reduction of  diabetic complications. Against 
this background, it became pertinent in this study to 
identify first, the level of  glycemic control status among 
T2DM patients under treatment. Secondly, investigate the 
demographic, anthropometric and clinical factor(s) asso-
ciated with glycemic control in T2DM patients with dif-
ferent diabetic complications in south-east Nigeria, and 
the extent of  association with or without accounting for 
joint influence of  significant predictor variables.
Patients and methods
Study design, setting and ethics
A cross-sectional survey was used for the study. Whilst 
this design was unable to establish a causal link19 between 
glycemic control status and studied demographic-clinical 
variables, it was a useful methodology for comparison 
and demonstration of  the relationship (association) be-
tween dependent variable (glycemic control status) and 
independent (demographics, anthropometrics & clinical) 
variables. By this design, it implies that changes in one 
variable accompany changes in another rather than cause 
and effect19 .This study was conducted at the diabetic 
clinic of  Nnamdi Azikiwe University Teaching Hospital, 
NAUTH, Nnewi. NAUTH is one of  the major tertiary 
hospitals located in South-East of  Nigeria. This study re-
ceived ethical approval in line with the Research Ethics 
Policy and Procedures of  the above named hospital prior 
to initiation of  the study.
Study population and sample size
The study population consists of  clinically confirmed 
T2DM out-patients under treatment, attending NAUTH 
for check-up. A sample size of  132 participants was cal-
culated for the study considering absolute precision of  
5% with a design effect of  1.5 using online method as 
described by Dean et al.20.  This was based on assumed 
population size of  1000 for the setting selected, and a 
documented prevalence of  T2DM in South-East Nigeria 
reported to be 6.7%21.  However, a higher number of  150 
patients were targeted to account for possible refusals 
and dropouts during the study.
Sampling procedure
Out-patients with T2DM who attends the diabetic clinic 
at NAUTH were recruited based on inclusion and exclu-
sion criteria set for the study. Patients were included if  
they satisfied the following inclusion criteria: were clini-
cally confirmed T2DM patients within the clinic, are 30 
years and above, under treatment for at least one year, and 
the willingness to participate and is able to give consent. 
However, those who met these inclusion criteria but were 
on drugs that could affect glucose metabolism e.g. steroid 
and B-blockers or pregnant for the females, were also ex-
cluded from the study.  Informed consent was provided 
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by each eligible patient who was willing to participate in 
the study after the purpose, risk and benefits of  the study 
was explained to all participants.   A convenient sampling 
method was used to select samples of  the population be-
tween June 2, 2013 and September 28, 2013. Finally, the 
study comprised data collected from 140 patients who 
cooperated in every stage of  the project.
Data collection
Demographic and anthropometric assessment
Patient’s clinical characteristics, including duration of  
T2DM since diagnosis, kind of  diabetic complications, 
and anti-diabetic medications and other concurrent med-
ications received by patients were obtained by review of  
patients’ medical records. The data on patients demo-
graphic (age and sex) were also obtained from the record 
while they underwent a standardised medical examina-
tion that included routine anthropometric and clinical 
assessment.  Weight was taken with patients having any 
heavy wears such as shoes, clothing and belts removed, 
using digital Soehnle electronic scales (Leifheit AS, Nas-
sau, Germany). Height was measured using a stadiometer 
with the participant standing erect in bare feet with head 
in the Frankfurt plane.  BMI was calculated by dividing 
weight (in kg) by height squared (in m2) and categorized 
using the WHO classification22 into: < 18.5 kg/m2 (un-
derweight), 18.5–24.9 kg/m2 (normal weight), 25–29.9 
kg/m2 (overweight), ≥ 30 kg/m2 (obese). Three BMI 
categories were created for the purpose of  the study by 
collapsing the under-weight with normal-weight to form 
a single category. WHR was calculated by dividing waist 
circumference (WC) by hip circumference (HC) all in 
centimetre (cm).WC was measured at the level of  the il-
iac crest while the participants breathed out gently using 
a measuring tape whereas measurement for the HC was 
taken at the maximal gluteal protrusion. The blood pres-
sure was measured twice in a sitting position after 5 min 
of  rest with   a mercury Sphygmomanometer according 
to a standard protocol. The average of  the two readings 
was considered as the blood pressure value in mmHg for 
each patient. To ensure reliability and validity of  results, 
all the patients’ data were collected using same measuring 
instrument.
Biochemical laboratory assessment
About 5ml of  venous blood was taken from each subject 
in a fasting state (i.e. after overnight fast) by  a medical 
laboratory scientist, who is a member of  the research 
team. About 2ml of  blood sample collected were dis-
pensed into EDTA anticoagulant bottle and 3ml into 
fluoride oxalate bottle. Whole blood for A1C assay was 
stored at 40C up to one week while the FPG was imme-
diately analysed. The quantitative determination of  A1C, 
an index of  glycemic control status in this study, was car-
ried out by Direct Enzymatic (fructosyl valine oxidase) 
method whereas FPG was estimated by glucose oxidase 
method using Randox kit.
In line with the therapeutic goal of  A1C in diabetes 
which is to maintain a value < 7% as recommended by 
the International Diabetes Federation (IDF) and Ameri-
can College of  Endocrinology (ACE)2, A1C data was di-
vided into two categories: Good glycemic control (< 7%) 
and poor glycemic  control ( 7%). This was to satisfy 
the purpose of  the study.
Data analysis
All data analyses were performed using SPSS, IBM® 
SPSS® Statistics for Windows Version 20.0(IBM Corp. 
Armonk, NY, USA). Descriptive analysis was carried out 
for the predictor (independent) variables (Age, Sex, BMI, 
WHR, FPG, Complications, SBP and diastolic blood pres-
sure (DBP)) and outcome (dependent) variable (A1C). 
The characteristics of  the sample were presented as per-
centage (frequencies) or mean SD where appropriate, 
first by demographic, anthropometric and clinical status 
and then as a function of  glycemic control categories. 
The association between variations in glycemic control 
status and variations in predictor variables were shown 
with cross-tabulation, and Pearson Chi-squared, Fisher's 
exact and student t-tests were used, where appropriate 
to select significant predictors of  good or poor glycemic 
control status. Binary logistic regression analysis was used 
to analyze the level of  association between significant pre-
dictor factors (Age, WHR, FPG and SBP) and the index 
of  glycemic control status (A1C). First, crude odds ratios 
(ORs) and 95% confidence intervals (CIs) for each signif-
icant predictor variable were calculated using univariable 
logistic regression. Secondly, the independence of  any as-
sociation was examined by accounting for the influence 
of  non-significant predictor variables such as Sex, BMI, 
Complications and DBP in a multivariable logistic regres-
sion model. Finally, the Odds Ratio and 95% confidence 
intervals were calculated to identify predictor(s) of  glyce-
mic control status using multivariable logistic regression 
model including only the significant predictor variables: 
Age, WHR, FPG, and SBP. p < 0.05 was considered sta-
tistically significant value for all comparisons.
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Results
General Characteristics of  the studied population
In Table 1, the descriptive statistics of  patient’s charac-
teristics were presented. The proportion of  males and 
females in 140 sample studied was made up of  approxi-
mately equal proportion of  patients, with only a difference 
of  10%. Fewer than half  (41.4%) of  the patients were 
elderly. Less than 10% of  the sample were underweight/
normal whereas more were either overweight (55.0%) or 
obese (35.7%) according to WHO classification of  obesi-
ty. Most of  the patients (67.5%) fall within low WHR. In 
addition, 61.3% of  the patients presented with different 
diabetic complications while 38.6% had no or unknown 
complications. Greater proportion of  the study popula-
tion (85.0%) had FPG outside tight control. The same 
was true of  the index of  glycemic control status (A1C). 
Majority (115; 83.3%) of  the patients showed poor gly-
cemic control status (A1C 7%) while 23 (16.7%) had 
good glycemic control status (A1C < 7%).
Table 1: Distribution of demographic and clinical characteristics of the studied patients 
  
Variables                                                                            N Patients; n (%) 
Demographic    
Age (yrs)                                                                           140 
Non elderly ( < 65years) 
Elderly ( 65years) 
  
82(58.6) 
58(41.4) 
Sex                                                                                     140 
Male 
Female 
  
77(55.0) 
63(45.0) 
Anthropometric 
Body mass Index   (BMI) (kg/m2)*                                   140 
Underweight/normal (<25) 
Overweight (25-29.9) 
Obese ( 30) 
  
  
13(9.3) 
77(55.0) 
50(35.7) 
Waist-Hip Ratio(WHR)                                                    139        
Low 
Medium 
High 
  
66(67.5) 
20(14.4) 
53(38.1) 
Clinical   
HbA1c (%)                                                                        138 
Good control(<7) 
Poor control( 7) 
  
23(16.7) 
115(83.3) 
Fasting plasma glucose  (FPG)(mmol/l)                            140 
Within tight control(3.9-7.2) 
Outside tight control(<3.9 or >7.2) 
  
21(15.0) 
119(85.0) 
Complications                                                                     140 
Neuropathy 
Retinopathy 
Nephropathy 
Foot amputation/or ulcer 
Non/unknown 
  
2(1.4) 
38(27.1) 
31(22.1) 
15(10.7) 
54(38.6) 
Blood pressure                                                                    140 
 Systolic blood pressure(mmHg) Mean (  SD) 
Diastolic blood pressure(mmHg) Mean (  SD) 
  
  
 144.32 (  21.03) 
88.19 (  13.15) 
  
*BMI = weight (kg) / (height x height) (m2) , Low-WHR: male  0.95 & female 0.80; medium-WHR: male 0.96 to 1.0 & female 0.81 to 0.85; high-WHR: male > 1.0 & female > 0.85 
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Potential predictors of  differences in glycemic con-
trol status
Table 2 shows that among the patients’ demographic, an-
thropometric and clinical variables: age, WHR, FPG, and 
SBP showed significant association with glycemic control 
status. Age ( = 7.747, p = 0.005) showed a significant 
association with glycemic control. Most (94.7%) of  the 
elderly patients ( 65 years) tend to show poor glyce-
mic control compared to non-elderly (75.3%), indicating 
that more of  the non-elderly (24.7%) had good glycemic 
control than the elderly (5.3%). WHR (  =6.775, p = 
0.034) showed a significant association, with most pa-
tients with medium or high WHR more likely to show 
poor glycemic control than those with low WHR who 
tend to have a good glycemic control status. FPG (  = 
36.497, p = 0.001) showed a significant association with 
glycemic control. Most of  the patients with FPG outside 
tight control tend to show poor glycemic control while 
those within tight control were more likely to have a good 
glycemic control status. Besides, patients associated with 
increased SBP were significantly more likely to have poor 
glycemic control, while those with decreased SBP tend 
to have a good glycemic control (F-ratio = 8.442, p = 
0.021). However, other studied variables were not signifi-
cantly associated with glycaemia control status in T2DM
Table 2:   Glycaemic control status with demographic and clinical variables in studied patients 
Variables                                         N                                                                                                                                                                      Patient; n (%)                 
                        HbA1c (%) 
Good control (<7) 
       23(16.7) 
Poor control (≥7) 
115(83.3) 
p-value 
Demographic   
Age(yrs)                                      138 
Non elderly (< 65years)  
Elderly (≥65years) 
 
20(24.7) 
3(5.3) 
 
61(75.3) 
54(94.7) 
 
0.005*b 
Sex                                               138 
Male 
female 
 
16(21.1) 
7(11.3) 
 
60(78.9) 
55(88.7) 
 
0.193b 
Anthropometric 
Body mass Index (BMI) (kg/m2) 138 
Underweight/normal (< 25)  
Overweight (25-29.9) 
Obese (≥ 30) 
 
 
3(23.1) 
11(14.5) 
9(18.4) 
 
 
10(76.9) 
65(85.5) 
40(81.6) 
 
 
0.687a 
Waist-Hip Ratio (WHR)               137 
Low 
medium 
high 
 
16(24.6) 
2(10.0) 
4(7.7) 
 
49(75.4) 
18(90.0) 
48(92.3) 
 
0.034*a 
Clinical    
Fasting plasma glucose               138 
(FPG)(mmol/l) 
Within tight control (3.9-7.2) 
Outside tight control (<3.9 or >7.2) 
 
 
13(61.9) 
10(8.5) 
 
 
8(38.1) 
107(91.5) 
 
 
0.001*c 
Complications                            138 
Neuropathy 
Retinopathy 
Nephropathy 
Foot amputation/or ulcer 
Non/unknown 
 
0(0.0) 
8(21.1) 
1(3.3) 
2(13.3) 
12(22.6) 
 
2(100.0) 
30(78.9) 
29(96.7) 
13(86.7) 
41(77.4) 
 
0.181a 
Blood pressure 
Systolic blood pressure(mmHg) (Mean ± SD) 
 
Diastolic blood pressure(mmHg) (Mean ± SD) 
 
 
137.04 ±15.35) 
 
86.09 ±10.76) 
 
146.11±21.74) 
 
88.75 ±13.65) 
 
0.021*d 
 
0.380d 
 
aPearson chi-square test; bContinuity correction; cFisher’s exact test; dStudents’ t-test; *statistically significant value (p < 0.05) 
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Level of  association of  significant predictor vari-
ables with glycemic control in T2DM subjects
In Table 3, the analysis using multivariate binary logistic 
regression model-predicting factors associated with gly-
cemic control in T2DM patients with different complica-
tions showed that; age (in model 1& 3), WHR (in model 
1), and FPG (in model 1, 2 &3) were significantly associ-
ated with glycemic control.
Age: Model 1(table 3), the odds of  a patient having poor 
glycemic control, is 6 times significantly (p = 0.006) more 
likely for elderly than for non-elderly (OR 5.90, 95% Cl: 
1.66-20.96). In model 2, the significant association be-
tween elderly and glycemic control disappeared as the OR 
for the elderly reduced (OR change from 5.90 to 3.94). 
This indicate that the elderly patients is not significantly 
(p = 0.066) more likely than non-elderly to report poor 
glycemic control (OR 3.94, 95% Cl: 0.91-17.05), when 
the influence of  non-significant predictor variables: sex, 
BMI, complications and DBP were accounted for. How-
ever, in model 3, after adjusting (i.e. accounting) for sig-
nificant predictor variables (Age, WHR, FPG and SBP 
jointly associated alone), although it attenuated the odds 
(OR 5.00, 95% CI: 1.19-20.96) of  poor glycemic control, 
it still remained significantly (p = 0.028) higher in the el-
derly compared to the non-elderly (Table 3).
WHR: High WHR is significantly (p = 0.022) more likely 
than low WHR to show poor glycemic control (OR 3.92, 
95% Cl: 1.22-12.57) in model 1. However, the overall as-
sociation between glycemic control status and WHR do 
not differ significantly either in model 2 or in model 3 
(Table 3).
FPG: Across the models (Table 3), the significant for 
the OR for patients outside tight FPG control has not 
changed much at all (OR change from 17.39(model 1) to 
10.85(model 2) to 12.08 (model 3). They are still signifi-
cantly more likely to show poor glycemic control than 
patients with FPG within tight control. This indicates 
that FPG is an independent predictor factor significantly 
associated with glycemic control status, and patients out-
side tight FPG control are more than 10 times more likely 
to show poor glycaemia control than those within tight 
FPG control.
Table 3: Multivariate binary logistic regression model-predicting demographic  
and clinical factors linked with glycemic control status 
 
                    glycaemic control status 
     Model 1         p-value Model 2          p-value Model 3   p-value 
Demographic 
predictor variable 
            
Age (yrs) 
Non elderly 
Elderly 
  
Ref (1.00) 
5.90(1.66-20.96) 
  
0.006* 
  
Ref (1.00) 
3.94(0.91-17.05) 
  
0.066 
  
Ref (1.00) 
5.00(1.19-20.96) 
  
   0.028* 
Anthropometric 
predictor variable 
  
WHR 
Low 
medium 
high 
  
  
  
Ref (1.00) 
2.94(0.61-14.07) 
3.92(1.22-12.57) 
  
  
  
  
0.177 
0.022* 
  
  
  
Ref(1.00) 
2.82(0.38-20.97) 
2.29(0.38-13.99) 
  
  
  
  
0.312 
0.368 
  
  
  
Ref (1.00) 
2.65(0.42-16.88) 
1.82(0.47-6.98) 
  
  
  
  
   0.302 
   0.386 
Clinical predictor 
variables 
            
Fasting plasma 
glucose (FPG) 
(mmol/l) 
Within tight control 
(3.9-7.2) 
Outside tight control 
(<3.9 or >7.2) 
  
  
Ref (1.00) 
  
17.39(5.83-51.90) 
  
  
  
  
  
0.001* 
  
  
Ref (1.00) 
  
10.85(3.10-37.96) 
  
  
  
0.001* 
  
  
Ref (1.00) 
  
12.08(3.64-40.09) 
  
  
  
0.001* 
Blood pressure 
Systolic blood 
pressure (mmHg)    
  
  
1.02(0.99-1.05) 
  
  
0.063 
  
  
  
1.02(0.98-1.06) 
  
  
0.331 
  
  
1.01(0.98-1.05) 
  
  
0.377 
                  Model 1: Crude (unadjusted) Odd Ratio for significant predictor variables 
                  Model 2: Adjusted Odd Ratio when the influence of non-significant predictor variables: Sex, BMI, complications and DBP were accounted for 
                  Model 3: Adjusted Odd Ratio when significant predictor variables: Age, WHR, FPG and SBP were accounted for. 
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Discussion
Type 2 diabetes mellitus accounts for approximately 80-
90% of  all cases of  diabetes in adults with varying fac-
tors affecting glycemic control level, a key strategy in pre-
venting as well as reducing possible complications arising 
from the disease. The present study investigated the gly-
cemic control status among T2DM adult patients under 
treatment, association of  demographic, anthropometric 
and clinical factor(s) with glycemic control in T2DM pa-
tients with complications, and the extent of  association 
with or without accounting for joint influence of  signifi-
cant predictor variables.
The study revealed that age, WHR, FPG as well as SBP 
distribution were significantly associated with differences 
in glycaemic control- assessed with A1C Measurement. 
Elderly patients ,  patients with high WHR  and a FPG 
outside the tight control range (< 3.9 or > 7.2 mmol/l) 
have  significantly increased odds of  poor glycemic con-
trol compared to  non-elderly,  patient with medium/low 
WHR  and a FPG within the tight control range of   3.9- 
7.2 mmol/l, respectively. However, after adjustment for 
significant predictor variables, only elderly patients and 
patients with FPG outside the tight control range were 
still significantly associated with increased odds of  poor 
glycaemia control status. These results, incongruent with 
other previous studies, indicate that the glycemic con-
trol status of  diabetic patients is significantly linked with 
age12,18,23,24, and FPG of  each patient in question23. In the 
contrary, these results disagree with a prior study25, that 
reported no significant association between age groups 
and glycemic control.
According to cumulative advantage/disadvantage theory, 
several explanatory factors relating to health outcomes 
are subject to modification with ageing26. Metabolic health 
changes associated with advanced age could possibly be 
a critical factor to consider in light of  the suboptimal or 
poor glycemic control status noted among such a hetero-
geneous group as the elderly27. For instance, normal ag-
ing is characterized with a progressive glucose intolerance 
arising from an impairment linked to glucose-induced 
insulin release. This age-related impairment has been at-
tributed to substantial decrease in beta-cell response to 
anti-diabetic agent (e.g. glucose-dependent insulinotropic 
polypeptide), particularly in hyperglycaemic state28.  More-
over, elderly patients have been reported to exhibit poor 
compliance to recommended therapy required to achieve 
optimal glycemic control18. Undoubtedly, however, most 
treatment options for this group has been derived to a 
large extent from data generated among the nonelder-
ly29,30,31 given the few evidence-based research works from 
which guidelines for treatment for the elderly patients can 
be derived27. Arguably, such treatment approach in terms 
of  achieving better glycemic control may likely favour the 
nonelderly patients than their elderly counterparts, which 
is the case in the present study. This finding is not consis-
tent with one prior study31. However, in elderly patients, 
more complex factors may be influencing the glycemic 
control status than in the younger adults as our finding 
suggests.
BMI in the current study was not a significant predictor of  
poor glycemic control, even though higher proportion of  
overweight/obese individuals were associated with poor 
glycemic control status. WHR (an indicator of  central ad-
iposity) was found to be a significant potential predictor 
of  poor glycemic control in diabetes. The prediction of  
T2DM, and perhaps its attendant poor glycemic control, 
has been suggested by clinical evidence to be better and 
stronger with indicators of  central adiposity (e.g. WHR) 
than with general adiposity (e.g. BMI)32,33. This was at-
tributed to the fact that central adiposity has been linked 
with impairment in glucose-insulin homeostasis leading 
to a decrease in both glucose tolerance and insulin-stim-
ulated glucose disposal33. According to Vazquez et al.33, 
the ability of  both adiposity indicators to predict T2DM 
may vary by demography such as ethnicity, sex and age. 
Perhaps, this is why our finding on BMI and poor glyce-
mic control did not echo a prior study24, which reported 
BMI as a significant predictor of  poor glycemic control. 
However, the finding on WHR as a significant predic-
tor of  poor glycemic control lends support to the clinical 
evidence, suggesting that indicators of  central adiposity 
are better predictors of   poor glycemic control in type 2 
DM32,33,34.
Majority of  patients in the study had FPG outside tight 
control. This, of  course, was not contrary to expectation, 
because previous documented evidence had reported that 
FPG have good predictive value for overall glycemic con-
trol35,36. Thus, in the context of  existing body of  research, 
the result in congruent with35,36 indicates that FPG is one 
biomarker that has a strong positive association with gly-
cated haemoglobin (A1C).
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Patients associated with increased SBP were significantly 
linked with poor glycemic control, while those with de-
creased SBP tend to show good glycemic control. For 
diabetic patients and other high-risk patients, the recom-
mended guidelines suggested lowering the systolic blood 
pressure to a treatment goal less than 130 mm Hg37. The 
guideline seems to uphold “the lower the better” approach 
to blood pressure control in diabetic individuals38, which 
the present finding, in agreement with prior study39, is in 
line with. Although, some authors have argued that below 
this recommended blood pressure guideline (130/80 mm 
Hg) in diabetes,increased risk for poor outcomes  have 
also been recorded40. 
Limitation of  the study
We recognised that multiple factors may interact to affect 
glycemic control. Our model, however, examined just a 
few of  those; demographics (age and sex), anthropomet-
ric (BMI and WHR) and clinical (FPG and BP) factors, 
variables capable of  yielding data less subject to bias. So-
cial-economic determinants (confounders) of  glycemic 
control status such as lifestyle/behavioural factors (diet, 
exercise, smoking etc), educational level, social class sta-
tus, knowledge of  self-care, etc were left unexplained, 
because information on such patients' data are meant to 
be collected with a questionnaire, a tool often subject to 
social desirability bias41 and recall bias, especially in study 
area such as ours. Postprandial plasma glucose (PPG) 
was not assessed in the study. Although PPG is a better 
predictor of  overall glycemic control than FPG, but that, 
is in the absence of  HbA1c. However, whether FPG or 
PPG is a better predictor of  glycemic control is still a 
subject of  debate42. Moreover, given that HbA1c was the 
measure of  glycemic control used in the present study, 
we included only FPG, the most common routine test for 
day-to-day monitoring of  diabetic patients in South-East-
ern Nigeria hospitals. Besides, FPG is considered to be 
the major contributor for glycation of  haemoglobin and 
can account for a shift in glycemic status of  the patients43.
However, our result may have been affected by those un-
accounted possible confounders.  As such, given the few 
predictor variables considered in our study, we wish to sub-
mit that our findings alone may not be sufficient enough 
to explain the difference in glycemic control in adult with 
T2DM. Furthermore, no causal associations between po-
tential predictor factors and poor glycemic control can 
be drawn because of  the cross-sectional design adopted 
in the study. Besides, this study did not account for the 
differences in drug treatment between various groups, a 
factor that may partly explain the differences in glycemic 
control status, particularly among elderly and non-elderly 
groups. Finally, as a single centre study which adopted 
convenience sampling technique for recruitment of  pa-
tients rather than random sampling, generalization of  
findings should be undertaken with caution-as only the 
patients who visited the NAUTH diabetic clinic during 
the period of  study were included.
Strength and clinical implication of  the study
This study is first of  its kind to show the level of  glyce-
mic control status among adult with T2DM in south-east 
Nigeria, suggesting that older adult ( 65 years) show 
poor glycemic control status regardless of  complications 
and the treatment options. Interestingly, also the study re-
vealed those significant predictors (age, WHR, FPG and 
SBP) of  poor glycemic control among the population. 
Findings indicate that these potential predictors of  poor 
glycemic control require adequate consideration during 
the course of  clinical management of  diabetes in order to 
improve, especially elderly patients’ outcome. Of  great-
er interest is the practical implication of  these findings, 
which apparently underpins the increasing body of  litera-
ture advocating a tailored management of  the disease for 
elderly patients44,45.
Conclusion
Taken together, age, WHR, FPG and SBP were signifi-
cantly associated with differences in glycemic control. 
The study revealed that the level of  DM management in 
south-east Nigeria is unsatisfactory, as majority showed 
poor glycemic control status, particularly among the el-
derly DM patients. Therefore, the complex interactions 
between potential predictors of  poor glycemic control 
among this age group -beyond the ones considered in 
this study- require further investigation in a wider scale 
such as population-based study in a low-income setting as 
ours. This may help to come up with improved treatment 
interventions and strategies that would favour better gly-
cemic control status, as such reduce the risk of  diabetic 
complication among the elderly population.
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